Palladio Biosciences, Inc.

Four months after failing in a mid-stage trial for Parkinson's disease, Sanofi 's venglustat, once seen as a key candidate in its pipeline, has been discontinued as a treatment for an inherited condi

Founded by UK life sciences venture capital firm Medicxi, Centessa Pharmaceuticals is headed up by industry heavyweights. Saurabh Saha, who was formerly Bristol Myers Squibb Company ’s head of R&D

Centessa Pharmaceuticals has launched with a first-of-its-kind model involving the merger of ten biotechs and $250m in series A backing. The new company was created through the merger of ten private

Artificial intelligence and machine learning have moved from buzzwords to long-term business strategies in biopharmaceutical drug development with hundreds of millions of dollars invested in individua